Skip to main content
Curiox Biosystems Co., Ltd. logo

Curiox Biosystems Co., Ltd. — Investor Relations & Filings

Ticker · 445680 ISIN · KR7445680002 KO Manufacturing
Filings indexed 130 across all filing types
Latest filing 2025-08-27 Director's Dealing
Country KR South Korea
Listing KO 445680

About Curiox Biosystems Co., Ltd.

https://www.curiox.com/

Curiox Biosystems is a life science technology company that develops and manufactures automated solutions for cell sample preparation. The company specializes in centrifuge-free technologies designed to standardize and improve workflows for cell analysis. Its core C-FREE™ technology utilizes a gentle, laminar flow-based washing method that replaces traditional centrifugation. This approach minimizes cell stress and loss, thereby enhancing cell retention, viability, and the quality of downstream analytical data. Curiox's product portfolio includes the Pluto series of automated liquid handling workstations and associated consumables. These systems automate critical steps such as cell washing, antibody staining, and antibody cocktailing for applications including flow cytometry, single-cell sequencing, and multiplex immunoassays, supporting research with various sensitive cell types.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. It details the sale of shares by an executive (Park Sungchul) of Curiox Biosystems. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which corresponds to the 'Director's Dealing' category.
2025-08-27 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Curiox Biosystems Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business descriptions, and management discussions, which are characteristic of an interim/quarterly report. It is not a mere announcement or certification, as it provides substantive financial data and operational details. H1 2025
2025-08-14 Korean
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (제1회차). This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2025-08-04 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the impact on the total number of shares. This type of corporate action, involving the issuance of new shares resulting from the conversion of debt, falls under the category of share issues or capital changes.
2025-07-28 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This document outlines a planned sale of shares by a major shareholder (ZIG Ventures Limited) of Curiox Biosystems. In the context of financial filings, reports detailing planned transactions by insiders or major shareholders are classified as 'Director's Dealing' (DIRS) as they pertain to insider trading activity and ownership changes.
2025-07-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their personal share transactions or changes in ownership. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2025-06-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.